Close Menu

neurological disorders

The test, called Neurome, is available from Athena, Quest Diagnostics' genetic testing business for neurological disorders, and is performed by Personalis.

Researchers also plan to launch a prospective randomized clinical trial to test the effectiveness of whole-genome sequencing compared to the standard of care.

NEW YORK (GenomeWeb News) – The Translational Genomics Research Institute held a ribbon-cutting today to launch a new clinic within the Center for Rare Childhood Disorders that will focus on using genomic and molecular techniques to diagnose and treat such disorders.

NEW YORK (GenomeWeb News) – An investigator at the Rehabilitation Institute of Chicago plans to use a new $9 million Transformative Research Award from the National Institutes of Health to develop DNA-based technologies that could be used to monitor neuron activity in living brains, RIC said on T

Isis Pharmaceuticals this week announced that it had formed a strategic alliance with Biogen Idec to develop antisense-based treatments for neurological disorders.

NEW YORK (GenomeWeb News) – The National Institute of Mental Health plans to provide around $4 million in Fiscal Year 2014 to support research efforts under the PsychENCODE project.

Isis Pharmaceuticals said this week that it has teamed with Biogen Idec to develop antisense-based drugs for neurological and neuromuscular disorders.

NEW YORK (GenomeWeb News) – Roche today announced that it has teamed with the Innovative Medicines Initiative to lead a consortium of industry and academic partners that will use stem cells for drug discovery research.

NEW YORK (GenomeWeb News) – Mutations in a gene called ATP1A3, which codes for a component of an ion transporter pump important to nerve cell function, are behind most cases of a sporadic neurological condition known as alternating hemiplegia of childhood, or AHC, according to a new Nature Ge

NEW YORK (GenomeWeb News) – Belgian molecular diagnostic company Multiplicom today announced a deal with French institutes ICM and ICAN to develop molecular diagnostic tests for the identification of genetic mutations associated with cardiovascular, metabolic, and neurological diseases.

Pages

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.